mRNA |
RITA |
CTRPv2 |
pan-cancer |
AAC |
-0.095 |
0.01 |
mRNA |
Rapamycin |
CTRPv2 |
pan-cancer |
AAC |
0.091 |
0.01 |
mRNA |
IPA-3 |
GDSC1000 |
pan-cancer |
AAC |
0.081 |
0.01 |
mRNA |
BRD-K02492147 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.02 |
mRNA |
BMS-536924 |
GDSC1000 |
pan-cancer |
AAC |
-0.079 |
0.02 |
mRNA |
XMD8-92 |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.02 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.086 |
0.02 |
mRNA |
Methotrexate |
CTRPv2 |
pan-cancer |
AAC |
-0.093 |
0.02 |
mRNA |
LFM-A13 |
GDSC1000 |
pan-cancer |
AAC |
0.082 |
0.02 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.086 |
0.02 |